PulmonaRy Inflammation and glucocorticoiD sensItivity for the prediCTion of BronchoPulmonary Dysplasia (PRIDICT-BPD): a feasibility study.

Completed

• Conditions: Bronchopulmonary dysplasia; chronic lung disease of prematurity; 10028971

• Registration Number: NL-OMON49781
• Lead Sponsor: Amsterdam Universitair Medische Centra, locatie VUmc

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 11 June 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 65

Inclusion Criteria

Newborn infant born <30 weeks of gestation

Exclusion Criteria

Congenital anomalies of any kind
Major surgery within 24 hours after birth

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>* To test whether the assays described above are feasible in this patient group</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>* To test whether the outcomes on the assays are associated with the<br /><br>development of BPD and the duration of respiratory support;<br /><br>* To test whether the outcomes on these assays are associated with<br /><br>pro-inflammatory markers;</p><br>